시장보고서
상품코드
1441281

세계의 모유 올리고당(HMO) 시장 규모, 점유율, 성장 분석, 유형별, 용도별, 산업별 - 산업 예측(2023-2030년)

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2´-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 모유 올리고당(HMO) 시장 규모는 2022년 1억 7,791만 달러로 평가되었고, 예측 기간(2024-2031년) 동안 연평균 9.7%의 연평균 복합 성장률(CAGR)로 2023년 1억 9,517만 달러에서 2031년까지 4억 932만 달러로 성장할 것으로 예상됩니다.

모유 올리고당(HMO) 시장은 영유아의 건강과 영양에 있어 중요한 성분으로 각광받고 있습니다. 복합당류로 분류되는 HMO는 모유에 자연적으로 존재하며 다양한 건강상의 이점을 제공합니다. HMO에 대한 이해도가 높아짐에 따라 HMO의 잠재적 활용 가능성은 유아 영양학뿐만 아니라 의료, 기능성 식품, 프리바이오틱스 보충제 등 다양한 분야로 확대되고 있습니다. 혜택에 대한 대중의 인식 증가와 모유에 더 가깝게 조제분유를 만들려는 목적이 시장 성장의 주요 동인입니다. 면역 및 장 건강을 강화하는 HMO의 능력은 자연적이고 전체론적인 치료법을 추구하는 추세와 일치합니다. 연구 개발에는 특정 건강상의 이점을 목표로 하는 고유한 HMO 성분의 식별 및 개발도 포함됩니다. 그러나 HMO 생산의 복잡성과 비용, 특히 모유에 존재하는 다양한 HMO를 복제하는 데는 어려움이 따릅니다. 규제 고려 사항과 잠재적인 지적 재산권 장애물도 시장 역학에 영향을 미치며, HMO에 대한 연구가 진행됨에 따라 시장은 유아 영양뿐만 아니라 다양한 생애 단계의 다양한 건강 요구 사항을 충족시키는 데에도 유망한 것으로 나타났습니다. 영양과 건강의 개념을 재정의할 수 있는 가능성은 의료 및 기능성 식품의 미래를 형성하는 데 있어 HMO 시장의 중요성을 강조합니다.

목차

주요 요약

  • 시장 개요
  • 번영과 쇠퇴

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 모유 올리고당(HMO) 시장 : 유형별

  • 시장 개요
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT

세계의 모유 올리고당(HMO) 시장 : 용도별

  • 시장 개요
  • 유아용 조제분유
  • 기능성 식품 및 음료
  • 식품/의료 보충제
  • 기타

세계의 모유 올리고당(HMO) 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • DuPont Nutrition & Biosciences
  • Nestle S.A.
  • Glycosyn LLC
  • Jennewein Biotechnologie GmbH
  • Elicityl
  • Inbiose
  • ZuChem Inc.
  • Glycom A/S
  • TMO Renewables Ltd.
  • Abbott Laboratories
  • Evolve Biosystems
  • Quantum Biotechnologies Inc.
  • Novalac
  • ZuChem Inc.
  • Clasado Biosciences
  • Metabiotics Corporation
  • Medolac Laboratories
  • HMO Research GmbH
  • Jennewein Biotechnologie
  • Holton BioSystems
LSH 24.04.11

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031).

The market for human milk oligosaccharides (HMOs) is gaining prominence as a crucial component in infant wellness and nutrition. HMOs, categorized as complex carbohydrates, naturally occur in human breast milk and offer various health benefits. These bioactive compounds support the development of the infant's immune system, gastrointestinal health, and cognitive functions. As our understanding of HMOs expands, their potential applications extend beyond infant nutrition to fields like medicine, functional foods, and prebiotic supplements. Increasing public awareness of the health benefits of HMOs and the aim to make infant formula more akin to breast milk are key drivers of market growth. The ability of HMOs to enhance immunological and gut health aligns with the rising trend of seeking natural and holistic remedies. Research focus also includes identifying and developing unique HMO compositions to target specific health benefits. However, challenges in HMO production complexity and cost arise, particularly in replicating the diverse range of HMOs present in breast milk. Regulatory considerations and potential intellectual property obstacles also influence market dynamics. As research on HMOs advances, the market shows promise not just in infant nutrition but also in addressing various health needs across different stages of life. The potential to redefine the concept of nutrition and well-being underscores the significance of the HMO market in shaping the future of healthcare and functional foods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Milk Oligosaccharides (HMO) and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Human Milk Oligosaccharides (HMO) Market Segmental Analysis

The Human Milk Oligosaccharides (HMO) Market is segmented on the basis of Type, Application, and Region. Based on Type, the market is segmented as, 2'-FL & 3-FL, Sialyllactose, LNT & LNnT. Based on Application the market is segmented as, Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)

Drivers of the Global Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits of human milk oligosaccharides (HMOs) is a significant driver for market growth. There is a rising demand for HMO-fortified products due to the role HMOs play in enhancing the immune system, cognitive development, and gut health in infants, as well as potential benefits for adults.

The incorporation of HMOs in formula products reflects consumers' desire for infant formulas that closely mimic the health advantages of breast milk. HMOs have become a vital component of infant nutrition as parents seek to provide their babies with optimal nourishment.

Restraints in the Global Human Milk Oligosaccharides (HMO) Market

The synthesis of HMOs is a challenging and intricate process. The scalability and cost-efficiency of manufacturing HMOs are hindered by the intricate and expensive methods required to replicate the diverse array of HMO structures found in breast milk.

It is essential to educate consumers about the benefits and importance of HMOs, especially in non-infant applications. While challenging, increasing awareness and understanding of the potential uses of HMOs is crucial for market growth.

Market Trends of the Global Human Milk Oligosaccharides (HMO) Market

Exploring Diverse Applications Beyond Infant Nutrition: While HMOs have traditionally been associated with infant feeding and are naturally present in breast milk, there is a growing trend to explore their potential in various other contexts. Researchers are investigating the use of HMOs in functional foods, dietary supplements, and pharmaceuticals to address a range of health conditions across different age groups.

Customization and HMO Profiling: As scientific understanding of HMOs advances, an increasing number of HMO profiles are being developed to closely mimic the composition of HMOs found in the breast milk of specific mothers. This customization offers the potential to provide new-borns with personalized nutrition tailored to their individual needs, as each mother's milk has a unique HMO composition.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Human Milk Oligosaccharides (HMO) Market by Type

  • Market Overview
  • 2'-FL & 3-FL
  • Sialyllactose
  • LNT & LNnT

Global Human Milk Oligosaccharides (HMO) Market by Application

  • Market Overview
  • Segmented as
  • Infant Formula
  • Functional Food & Beverages
  • Food/Medical Supplements
  • and Others

Global Human Milk Oligosaccharides (HMO) Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • DuPont Nutrition & Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glycosyn LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jennewein Biotechnologie GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elicityl
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inbiose
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZuChem Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glycom A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TMO Renewables Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Evolve Biosystems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quantum Biotechnologies Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novalac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZuChem Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clasado Biosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metabiotics Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medolac Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HMO Research GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jennewein Biotechnologie
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Holton BioSystems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제